Founder of CMEA Capital to Speak on Biofuel Investment Opportunities at 2009 World Biofuels Markets Conference

SAN FRANCISCO, CA--(Marketwire - March 10, 2009) - Thomas Baruch, founder and managing
director of CMEA Capital, will speak at the World Biofuels Markets
Conference, Europe's largest biofuels congress and exhibition in Brussels,
Belgium. He will give his presentation on biofuel investment opportunities
at 9:15 a.m. on March 16, as part of the keynote session at the event's
Investment Forum.



Thomas Baruch has been investing in energy and materials for more than
thirty years. He is a member of the Energy Security, Innovation and
Sustainability (ESIS) Initiative Steering Committee of the Council on
Competitiveness. He is chairman of the board at Codexis and Intermolecular
and sits on the boards of several other energy companies, including
Solyndra and Luminus Devices.



His presentation will address investment opportunities and challenges in
the biofuels market. In particular, it will focus on the technology which
could be responsible for massively accelerating the development of
biofuels: combinatorial synthesis. Combinatorial synthesis is a novel
process for testing chemical compounds at rates several orders of magnitude
faster than traditional approaches to the development of complex chemical
compounds. CMEA Capital has pioneered investments in a number of portfolio
companies that use combinatorial synthesis including Symyx, Intermolecular
and Wildcat Discovery.



"There is no doubt that the United States needs to overcome its dependence
on oil in order to achieve energy security. We can't do this without
biofuels," Thomas Baruch said. "Scientific innovators, like CMEA portfolio
company Codexis, are leading the way with next-generation biofuels and
partnerships with forward-thinking companies, like Shell Oil. We have the
necessary technology today. With more energy industry partnerships and the
right government policies, we can achieve energy independence," he said.



Codexis develops biocatalysts used to create powerful, efficient and
cleaner chemistry-based manufacturing processes in the life sciences,
bioindustrial and chemical marketplaces.



Alan Shaw, Ph.D., Codexis president and CEO, said, "Codexis is deploying
its powerful technology platform to meet critical environmental and energy
needs worldwide. We are developing new, efficient, clean ways to create
transportation fuels, carbon management technologies and other products
that will lead a global market expected to grow for decades."



About CMEA Capital:



CMEA Capital provides capital and counseling to entrepreneurs and investors
in the life sciences, information technology, and energy & materials
sectors. Through its combination of solid scientific credentials and
seasoned management expertise, CMEA identifies, funds and manages new
businesses based on the emerging, interdisciplinary science required to
meet the challenges and opportunities of a rapidly changing global economy.
The firm currently manages seven funds representing investments in excess
of $1 billion. CMEA has been an early stage investor in many leading
companies, including A123Systems, Codexis, Entropic (ENTR), Flextronics
(FLEX), Magma (LAVA), Maxygen (MAXY), Silicon Spice (BRCM), Solyndra, and
Symyx (SMMX).